SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Airway microbiota in young people across four continents differ by country, asthma status and inflammatory phenotype

Taylor, SL; Brooks, CR; Pembrey, L; Manning, SK; Elms, L; Mpairwe, H; Figueiredo, CA; Oviedo, AY; Chico, M; Burmanje, J; et al. Taylor, SL; Brooks, CR; Pembrey, L; Manning, SK; Elms, L; Mpairwe, H; Figueiredo, CA; Oviedo, AY; Chico, M; Burmanje, J; Ali, H; Nambuya, I; Tumwesige, P; Robertson, S; Rutter, CE; van Veldhoven, K; Ring, SM; Barreto, ML; Cooper, PJ; Cruz, ÁA; Pearce, N; Rogers, GB; Douwes, J (2026) Airway microbiota in young people across four continents differ by country, asthma status and inflammatory phenotype. Thorax. ISSN 0040-6376 https://doi.org/10.1136/thorax-2025-222965
SGUL Authors: Cooper, Philip John

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (3MB)
[img] PDF (Supplementary material 1) Supporting information
Download (1MB)
[img] PDF (Supplementary material 2) Supporting information
Download (310kB)

Abstract

Background Asthma is an umbrella diagnosis encompassing distinct pathophysiological mechanisms. While a global problem, our understanding of the interplay between respiratory microbiology and airway inflammation is largely from populations in high-income settings. As a result, treatment approaches align poorly with asthma characteristics in less studied populations. Objective To identify conserved and geographically distinct relationships between airway inflammation and microbiota characteristics in young people with and without asthma. Methods We conducted a cross-sectional study performing inflammatory phenotyping, microbiota analysis and enumeration of total bacteria, Haemophilus influenzae and Moraxella catarrhalis on 488 induced sputum samples from participants from Brazil (asthma: 68; non-asthma: 8), Ecuador (asthma: 89; non-asthma: 30), Uganda (asthma: 61; non-asthma: 8), New Zealand (asthma: 129; non-asthma: 58) and the UK (asthma: 25; non-asthma: 20). Microbiota characteristics were compared by country, asthma status and inflammatory characteristics, adjusting for age and sex. Results Asthma inflammatory phenotypes and microbiology differed between countries, with Uganda characterised by higher neutrophils, microbial diversity and bacterial abundance. Comparison of airway inflammation with microbiota characteristics showed conserved relationships across centres, with airway neutrophil proportion explaining variance in microbiota Bray-Curtis dissimilarity (p<0.001) and being positively associated with bacterial abundance, including H. influenzae and M. catarrhalis load (all p<0.05). In contrast, eosinophil proportion was less strongly associated with microbiota dissimilarity (p=0.033) and only associated with Streptococcus abundance. Country-specific associations between airway inflammation and microbiology were evident. Conclusion Both airway inflammation and microbiology varied geographically in young people with asthma. Associations between microbiota characteristics and neutrophilic phenotype were conserved.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: Asthma, Asthma Epidemiology, Asthma Mechanisms, Microbiota
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Thorax
ISSN: 0040-6376
Language: en
Related URLs:
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
101020088European Research Councilhttp://dx.doi.org/10.13039/501100000781
668954European Research Councilhttp://dx.doi.org/10.13039/501100000781
FP7/2007–2013Seventh Framework ProgrammeUNSPECIFIED
21706/Z/19/ZMedical Research Councilhttp://dx.doi.org/10.13039/501100000265
APP2008625National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
UNSPECIFIEDNZ HRC Sir Charles Hercus FellowshipUNSPECIFIED
20-MAU-071Marsden Fundhttps://doi.org/10.13039/501100009193
14/474Health Research Council of New Zealandhttps://doi.org/10.13039/501100001505
15/311Health Research Council of New Zealandhttps://doi.org/10.13039/501100001505
Dates:
Date Event
2026-01-30 Published Online
2025-12-15 Accepted
URI: https://openaccess.sgul.ac.uk/id/eprint/118251
Publisher's version: https://doi.org/10.1136/thorax-2025-222965

Actions (login required)

Edit Item Edit Item